These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 12467504)

  • 41. Identification and validation of nebulized aerosol devices for sputum induction.
    Davidson WJ; Dennis J; The S; Litoski B; Pieron C; Leigh R
    Can Respir J; 2014; 21(2):101-6. PubMed ID: 24288700
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nebulizer performance: AFLM study. Association Française de Lutte contre la Mucoviscidose.
    Faurisson F; Dessanges JF; Grimfeld A; Beaulieu R; Kitzis MD; Peytavin G; Lefebvre JP; Farinotti R; Sautegeau A
    Respiration; 1995; 62 Suppl 1():13-8. PubMed ID: 7792434
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Randomized controlled trial of salbutamol aerosol therapy via metered dose inhaler-spacer vs. jet nebulizer in young children with wheezing.
    Deerojanawong J; Manuyakorn W; Prapphal N; Harnruthakorn C; Sritippayawan S; Samransamruajkit R
    Pediatr Pulmonol; 2005 May; 39(5):466-72. PubMed ID: 15786440
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aerosol therapy: the special needs of young children.
    Janssens HM; Tiddens HA
    Paediatr Respir Rev; 2006; 7 Suppl 1():S83-5. PubMed ID: 16798606
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Performance comparison of nebulizer designs: constant-output, breath-enhanced, and dosimetric.
    Rau JL; Ari A; Restrepo RD
    Respir Care; 2004 Feb; 49(2):174-9. PubMed ID: 14744267
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Time course of drug concentrations in nebulizers and nebulized solutions].
    Ito K; Kikuchi S; Yamada M; Torii S; Yoshida M
    Arerugi; 1992 Jul; 41(7):772-7. PubMed ID: 1444830
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Nebulization aerosol therapy in otorhinolaryngology. Review of the literature].
    Bonfils P
    Ann Otolaryngol Chir Cervicofac; 1997; 114(5):147-56. PubMed ID: 9686025
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Miniature inhalation therapy platform using surface acoustic wave microfluidic atomization.
    Qi A; Friend JR; Yeo LY; Morton DA; McIntosh MP; Spiccia L
    Lab Chip; 2009 Aug; 9(15):2184-93. PubMed ID: 19606295
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Studies on aerosol delivery of plasmid DNA using a mesh nebulizer.
    Arulmuthu ER; Williams DJ; Baldascini H; Versteeg HK; Hoare M
    Biotechnol Bioeng; 2007 Dec; 98(5):939-55. PubMed ID: 17497741
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Design and testing of aerosol delivery systems for reproducible clinical performance.
    Cipolla DC; Farr SJ; Gonda I; Herst CV; Lee RY; Lloyd P; McKinley G; Rubsamen R; Schuster J; Zellhoefer C
    J Aerosol Med; 1998; 11 Suppl 1():S84-8. PubMed ID: 10180738
    [No Abstract]   [Full Text] [Related]  

  • 51. New ipratropium formulation to decrease nebulization time.
    Majoral C; Vecellio L; Grimbert D; de Monte M; le Guellec C; Ingremeau V; Minois C; Cordeau E; Paintaud G; Steinberg A; Diot P
    Respir Med; 2007 Feb; 101(2):237-45. PubMed ID: 16854578
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aerosols and anti-infectious agents.
    Diot P; Dequin PF; Rivoire B; Gagnadoux F; Faurisson F; Diot E; Boissinot E; Le Pape A; Palmer L; Lemarié E
    J Aerosol Med; 2001; 14(1):55-64. PubMed ID: 11495486
    [TBL] [Abstract][Full Text] [Related]  

  • 53. That's cool!--Nebulization of thermolabile proteins with a cooled vibrating mesh nebulizer.
    Hertel S; Pohl T; Friess W; Winter G
    Eur J Pharm Biopharm; 2014 Jul; 87(2):357-65. PubMed ID: 24662437
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The salt output of a nebulizer--a comparison between two nebulizer types.
    Eklund L; Sundblad BM; Malmberg P; Larsson K
    Respir Med; 2000 Feb; 94(2):139-44. PubMed ID: 10714419
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nebulizer delivery of micafungin aerosols.
    Alexander BD; Winkler TP; Shi S; Ashley ES; Hickey AJ
    Pharmacotherapy; 2011 Jan; 31(1):52-7. PubMed ID: 21182358
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The influence of fluid physicochemical properties on vibrating-mesh nebulization.
    Ghazanfari T; Elhissi AM; Ding Z; Taylor KM
    Int J Pharm; 2007 Jul; 339(1-2):103-11. PubMed ID: 17451896
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nebulizer use and maintenance by cystic fibrosis patients: a survey study.
    Lester MK; Flume PA; Gray SL; Anderson D; Bowman CM
    Respir Care; 2004 Dec; 49(12):1504-8. PubMed ID: 15571641
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Liquid atomizing: nebulizing and other methods of producing aerosols.
    Lange CF; Finlay WH
    J Aerosol Med; 2006; 19(1):28-35. PubMed ID: 16551212
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nebulized bronchodilator formulations: unit-dose or multi-dose?
    Rau JL; Restrepo RD
    Respir Care; 2003 Oct; 48(10):926-39. PubMed ID: 14525629
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The expanding role of aerosols in systemic drug delivery, gene therapy, and vaccination.
    Laube BL
    Respir Care; 2005 Sep; 50(9):1161-76. PubMed ID: 16122400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.